May 18, 2026
Our Work
Latham Represents Gossamer Bio, Inc. in Exchange Offer and Consent Solicitation Transaction to Eliminate Over US$120 Million of Debt With Existing Noteholder Support
Multidisciplinary team advises the biopharmaceutical company in the transaction.